Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2026 07:30 ET | Source: Angitia Incorporated Limited

Angitia Biopharmaceuticals Announces $130 Million Series D Financing

- Financing co-led by Frazier Life Sciences and Venrock Healthcare Capital Partners with significant participation from other new and existing investors - Proceeds will support the ongoing clinical...
January 12, 2026 07:30 ET | Source: Angitia Incorporated Limited

Angitia Biopharmaceuticals Announces Dosing of First Participant in Phase 2 IDUN Trial of AGA2115 for the Treatment of Osteogenesis Imperfecta

- Phase 2 trial of adults with Osteogenesis Imperfecta (OI) is enrolling patients in the US and EU WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a...